Enigmatic role of exosomes in breast cancer progression and therapy

• Published in: Life sciences (1973) Vol. 289; p. 120210
• Main Authors: Famta, Paras, Shah, Saurabh, Khatri, Dharmendra Kumar, Guru, Santosh Kumar, Singh, Shashi Bala, Srivastava, Saurabh
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 15.01.2022; Elsevier BV
• Subjects: Biomolecules; Biopsy; Blood circulation; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - epidemiology; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; cancer progression; Cell Communication; Cell Movement; Chemoresistance; Chemotherapy; Circulating MicroRNA - metabolism; Dormancy; Epigenetics; Exosomes; Exosomes - metabolism; Female; Humans; Immunosuppression; Immunotherapy; Metastases; Neoadjuvant Therapy; Neoplasm Metastasis; Pathophysiology; Prevalence; RNA, Long Noncoding - metabolism; RNA, Neoplasm - metabolism; Tumors; BC; Chemoresistance; Exosomes; EGFR; SNARE; ILV; MSCs; cancer progression; PTX; Immunotherapy; PD-L1; TDEs; lnc RNA; CSCs; ESCRT; HIF; MiRNA; STAT3; Breast cancer; DOX; IL-1β; EMT; CFs; FAK; RAB; PG; MVB; Epigenetics; TGF-β1; TXNIP; PD-1
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2021.120210

Breast cancer (BC) is reported to be the leading cause of mortality in females worldwide. At the beginning of the year 2021, about 7.8 million women were diagnosed with BC in past 5 years. High prevalence and poor neoadjuvant chemotherapeutic efficacy has motivated the scientists around the globe to investigate alternative management strategies. In recent years, there has been an exponential rise in the scientific studies reporting the role of tumor derived exosomes (TDEs) in the BC pathophysiology and management. TDEs play an important role in the intercellular communication and transportation of biomolecules. This manuscript reviews the role of exosomes in the BC pathophysiology, diagnosis, and therapy. Role of TDEs in the mechanistic pathways of BC metastasis, immunosuppression, migration, dormancy and chemo-resistance is extensively reviewed. We have also highlighted the epigenetic modulations orchestrated by exosomal miRNAs and long noncoding RNAs (lnc RNAs) in the BC environment. Liquid biopsies analyzing blood circulating exosomes for early and accurate detection of the BC have been discussed. Characterization of exosomes, strategies to use them in BC chemotherapy, BC immunotherapy and potential challenges that will present themselves in translating exosomes based technologies to market are discussed. [Display omitted]